Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance

Qiu,Liansheng; Lv,Jiabao; Chen,Yimin; Wang,Jiarong; Wu,Ruishan

doi:10.3892/ol.2015.3799

Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance

Authors:
- Liansheng Qiu
- Jiabao Lv
- Yimin Chen
- Jiarong Wang
- Ruishan Wu
View Affiliations

Affiliations: Department of Otorhinolaryngology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China, Department of Otorhinolaryngology, The Second Hospital of Xiamen, Xiamen, Fujian 361000, P.R. China
Published online on: October 12, 2015 https://doi.org/10.3892/ol.2015.3799
Pages: 3756-3760

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to determine the effect of S‑phase kinase‑associated protein 2 (Skp2) and cyclin‑dependent kinase inhibitor p27kinase‑interacting protein 1 (p27kip1) protein expression on the occurrence and development of hypopharyngeal squamous cell carcinoma. The protein expression levels of Skp2 and p27kip1 were detected in 42 hypopharyngeal squamous cell carcinoma and 15 normal hypopharyngeal mucous membrane specimens using the an immunohistochemical PV‑9000 two‑step method. The expression levels of Skp2 protein were significantly different in hypopharyngeal squamous cell carcinomas and normal hypopharyngeal mucous membranes (61.90 vs. 26.67%; P<0.05). By contrast, the protein expression levels of Skp2 were significantly positively correlated with tumor T stage (rs=0.329, P<0.05) and cervical lymph node metastasis (rs=0.402, P<0.05). Furthermore, the expression levels of p27kip1 protein were significantly different in hypopharyngeal squamous cell carcinomas and normal hypopharyngeal mucous membranes (11.9 vs. 53.33%; P<0.05), while p27kip1 protein expression was significantly negatively correlated with tumor T‑stage (rs=‑0.351, P<0.05) and cervical lymph node metastasis (rs=‑0.371, P<0.05). Notably, a significant negative correlation was observed between the expression levels of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma (P<0.05). In addition, abnormal expression levels of Skp2 and p27kip1 proteins were observed in hypopharyngeal squamous cell carcinoma tissues. Thus, Skp2 and p27kip1 proteins may be involved in the development of hypopharyngeal squamous cell carcinoma. The current study proposed that combined detection of Skp2 and p27kip1 may be useful for assessing the characteristics and prognosis of hypopharyngeal squamous cell carcinoma.

View Figures

View References

1	Slingerland J and Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol. 183:10–17. 2000. View Article : Google Scholar : PubMed/NCBI
2	Inuzuka H, Gao D, Finley LW, et al: Acetylation-dependent regulation of Skp2 function. Cell. 150:179–193. 2012. View Article : Google Scholar : PubMed/NCBI
3	Ezoe S, Matsumura I, Nakata S, et al: GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood. 100:3512–3520. 2002. View Article : Google Scholar : PubMed/NCBI
4	Sicari BM, Troxell R, Salim F, Tanwir M, Takane KK and Fiaschi-Taesch N: c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein. Endocrinology. 153:861–872. 2012. View Article : Google Scholar : PubMed/NCBI
5	Dai DM and Zhu H: Expression of P27kip1 and Skp2 in basal cell carcinoma and its clinical pathological characters. Int Oncol. 38:158–160. 2011.
6	Suzuki S, Fukasawa H, Misaki T, et al: The amelioration of renal damage in Skp2-deficient mice canceled by p27kipl deficiency in Skp2-/-p27/-mice. PLoS One. 7:e362492012. View Article : Google Scholar : PubMed/NCBI
7	Nakayama K, Nagahama H, Minamishima YA, et al: Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1) polyploidy and centrosome overduplication. EMBO J. 19:2069–2081. 2000. View Article : Google Scholar : PubMed/NCBI
8	Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J and Krek W: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA. 98:5043–5048. 2001. View Article : Google Scholar : PubMed/NCBI
9	Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I and Takata T: High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 61:7044–7047. 2001.PubMed/NCBI
10	Shintani S, Li C, Mihara M, Hino S, Nakashiro K and Hamakawa H: Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology. 65:355–362. 2003. View Article : Google Scholar : PubMed/NCBI
11	Dong Y, Sui L, Watanabe Y, Sugimoto K and Tokuda M: S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. Oncol Rep. 10:321–325. 2003.PubMed/NCBI
12	Signoretti S, Di Marcotullio L, Richardson A, et al: Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 110:633–641. 2002. View Article : Google Scholar : PubMed/NCBI
13	Patel SG and Shah JP: TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin. 55:242–258; quiz 261–262, 264. 2005. View Article : Google Scholar : PubMed/NCBI
14	Zhang H, Kobayashi R, Galaktionov K and Beach D: p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 82:915–925. 1995. View Article : Google Scholar : PubMed/NCBI
15	Carrano AC, Eytan E, Hershko A and Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1:193–199. 1999. View Article : Google Scholar : PubMed/NCBI
16	Yokoi S, Yasui K, Saito-Ohara F, et al: A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol. 161:207–216. 2002. View Article : Google Scholar : PubMed/NCBI
17	Coats S, Flanagan WM, Nourse J and Roberts JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 272:877–880. 1996. View Article : Google Scholar : PubMed/NCBI
18	Nakatsuka S, Liu A, Yao M, et al: Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies. Int J Oncol. 22:561–568. 2003.PubMed/NCBI
19	Ewald JA and Jarrard DF: Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer. Transl Oncol. 5:278–287. 2012. View Article : Google Scholar : PubMed/NCBI
20	Rose AE, Wang G, Hanniford D, et al: Clinical relevance of SKP2 alterations in metastatic melanoma. Pigment Cell Melanoma Res. 24:197–206. 2011. View Article : Google Scholar : PubMed/NCBI
21	Baresova P, Pitha PM and Lubyova B: Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability. J Biol Chem. 287:16199–16208. 2012. View Article : Google Scholar : PubMed/NCBI
22	Tschen SI, Georgia S, Dhawan S and Bhushan A: Skp2 is required for incretin hormone-mediated β-cell proliferation. Mol Endocrinol. 25:2134–2143. 2011. View Article : Google Scholar : PubMed/NCBI
23	Dowen SE, Scott A, Mukherjee G and Stanley MA: Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression. Int J Cancer. 105:326–330. 2003. View Article : Google Scholar : PubMed/NCBI